Cosmo Pharmaceuticals NV (CMOPF)
156.38
-2.62
(-1.65%)
USD |
OTCM |
Feb 20, 09:30
Cosmo Pharmaceuticals Market Cap : 2.639B for Feb. 20, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Amarin Corp. Plc | 326.65M |
| Jazz Pharmaceuticals Plc | 10.32B |
| Prothena Corp. Plc | 474.78M |
| Iterum Therapeutics Plc | 10.17M |
| GH Research Plc | 960.53M |
Market Cap Related Metrics
| PS Ratio | 12.95 |
| PEG Ratio | 0.1040 |
| Price to Free Cash Flow | 34.92 |
| Price | 156.38 |
| Earnings Yield | 2.27% |
| PEGY Ratio | 0.1033 |
| Operating PE Ratio | 44.55 |
| Normalized PE Ratio | 46.20 |